Status:
RECRUITING
Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema
Lead Sponsor:
SCF Pharma
Collaborating Sponsors:
Institut de recherche clinique du littoral (IRCL)
Conditions:
Eczema
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This exploratory study aims to verify the impact on the severity of eczema as well as the prebiotic potential of a daily application of Omega-3 serum and cream on a skin with eczema. This study will a...
Detailed Description
Omega-3 fatty acids and more particularly EPA are recognized as fatty acids promoting the resolution of inflammation unlike omega-6 fatty acids, which are pro-inflammatory. The skin, which is the larg...
Eligibility Criteria
Inclusion
- Participant aged of at least 18 years old.
- Participant diagnosed with eczema who did not use corticosteroids in the 14 days prior to study day 1;
- Available for the entire duration of the study and willing to participate based on the information provided in the ICF duly read and signed by the latter.
- Participant without intellectual problems likely to limit the validity of consent to participate in the study and compliance with protocol requirements, having the ability to cooperate adequately, understand and observe the instructions of research staff.
Exclusion
- None
Key Trial Info
Start Date :
December 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06155513
Start Date
December 20 2023
End Date
May 1 2025
Last Update
April 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SCF Pharma
Rimouski, Quebec, Canada, G0K 1P0